FDA Warns About Safety of Custom-Made Ozempic
Synopsis by WSJ Jun 01 23
Some people have turned to pharmacies to make a solution containing the active ingredient, semaglutide.Read full article 
WSJ: FDA Warns About Safety of Custom-Made Ozempic
Story Details
| Last Updated | Jun 01 23 |
| Total Articles | 1 |
Main Topics
More news on this subject
Previous
German watchdog approves Novo's acquisition of Cardior Pharmaceuticals: The German cartel office has approved a deal by Denmark's Novo Nordisk to purchase ...
reuters.com/business/healthcare-pharmaceuticals/german-watchdog-approves-novos-acquisition-cardior-pharmaceuticals-2024-04-18/
India's Biocon developing its own version of Wegovy, clinical trial likely next year
reuters.com/business/healthcare-pharmaceuticals/indias-biocon-developing-its-own-version-wegovy-clinical-trial-likely-next-year-2024-04-18/
Quick Glance: Biocon Developing Own Version of Wegovy, Plans Clinical Trial
- Indian pharmaceutical company Biocon is working on developing its own version of Novo Nordisk's popular Wegovy and is likely to conduct a clinical trial next year to enter the growing weight-loss drug market.
- Biocon's CEO, Siddharth Mittal, has expressed the company's intention to develop semaglutide, the active ingredient in Wegovy, for the Indian market, even if it requires a clinical trial.
- Biocon aims to introduce generic versions of weight-loss drugs in emerging markets such as Brazil, Mexico, and Saudi Arabia before the patent for semaglutide expires in those countries in 2026.
- The company is striving to obtain a waiver on clinical trials from Indian regulators and submit bioequivalence studies to demonstrate the effectiveness of their version of semaglutide. Biocon is making significant investments in generics research and development, including peptides for weight-loss drugs.
The weight loss drug Ozempic is not linked to suicidal thoughts, regulators say: The European Medicines Agency announced the findings of its nine-month review
qz.com/ema-ozempic-suicidal-thoughts-1851406145
It’s Not Just Weight Loss. Eli Lilly Obesity Drug Works on This Chronic Condition.
barrons.com/articles/eli-lilly-stock-obesity-sleep-1229e0a6
Paid articlePaid
Bullish signal for biotech shares: Will this solve one of Novo Nordisk's biggest problems?
boerse-online.de/nachrichten/aktien/bullisches-signal-fuer-biotech-aktie-loest-das-eines-der-groessten-probleme-von-novo-nordisk-20355342.html
DJT Stock Falls Again. Trump’s Stake Is Down by More Than $2 Billion.: Trump Media & Technology Group shares were dropping again early on Tuesday after a sharp ...
barrons.com/articles/djt-stock-price-sell-buy-trump-media-truth-social-f97b0e23
Paid articlePaid Vertex Pharmaceuticals Seeks a Second Act With $4.9B Deal to Buy Alpine Immune: Vertex Pharmaceuticals announced a $4.9 billion deal to buy Alpine Immune ...
barrons.com/articles/vertex-pharmaceuticals-stock-alpine-immune-deal-a3a27f8e
Paid articlePaid Solventum Stock Is Cheap. Why Wall Street Says to Wait.: Solventum stock picked up two new ratings this week. Wall Street wants to see more growth from the 3M ...
barrons.com/articles/solventum-stock-price-3m-spinoff-4f6025e7
Paid articlePaid
Here’s Who Still Owns Trump Media Stock—and Could Be Getting Ready to Sell: Shares (ticker: DJT) of the Trump Media, the Truth Social owner, have plunged and may ...
barrons.com/articles/djt-stock-ownership-sales-31c6586b
Paid articlePaid DJT Stock Slips. Truth Social Co-Founders Are Challenging Trump Media Lockup.
barrons.com/articles/djt-stock-price-buy-sell-trump-media-truth-social-6acedadd
Paid articlePaid Who Is Buying DJT Stock? It’s a Mystery.: Public disclosures for Trump Media’s DJT, like all stocks, show very little about who’s ultimately behind the trading ...
barrons.com/articles/djt-truth-social-trump-media-stock-buying-a7bffe7d
Paid articlePaid DJT Stock Slips. Trump Is Suing Co-Founders of the Truth Social Parent.: Trump Media & Technology Group was falling early on Wednesday. Its majority owner Donald ...
barrons.com/articles/djt-stock-price-trump-truth-social-buy-sell-d2249f43
Paid articlePaidQuick Glance: Donald Trump's Media Company Faces Financial Challenges in 2023
- Following a high-profile stock market debut, Donald Trump's social media company reported significant losses, with nearly $58.2 million lost last year, resulting in a stock price decline of over 21%.
- Revenue for Trump Media in 2023 totaled $4.1 million, showing an increase from $1.5 million in 2022.
- Trump Media began trading on the Nasdaq under the symbol DJT on March 26, experiencing volatility as the stock closed at $48.66 after Monday's sell-off.
- Analysts have drawn comparisons between the excitement surrounding Trump Media and the meme stock frenzy that boosted shares of companies like GameStop and AMC Entertainment in 2021.
Abbott Labs Stock Is Slipping. Disappointing Guidance Trumps a Strong Quarter.
barrons.com/articles/abbott-labs-earnings-stock-price-8645ed58
Paid articlePaid EU regulator to review reports of suicidal thoughts and weight loss drugs: A European Medicines Agency committee will this week hold a meeting related to its ...
reuters.com/business/healthcare-pharmaceuticals/eu-health-regulator-discuss-any-link-between-weight-loss-drugs-suicidal-thoughts-2024-04-08/
Weed Stocks Are in the Green Again: Weed now seems back in vogue. From last summer’s low, the Pure US Cannabis ETF has doubled, to a recent $10.25.
barrons.com/articles/aurora-trulieve-curaleaf-canopy-cannabis-weed-stocks-20d424f2
Paid articlePaid Costco is now prescribing Ozempic, Wegovy, and other weight loss drugs: The warehouse club is offering prescriptions for weight loss drugs through its health ...
qz.com/costco-ozempic-wegovy-weight-loss-drugs-prescription-1851382263
Paid articlePaid Today, General Electric Will Be No More—Sort of.: The venerable conglomerate is being broken into three pieces.
barrons.com/articles/general-electric-breakup-1babaaa5
Paid articlePaid Eli Lilly’s Ozempic Competitors Face Risks. Why the Stock Has More Upside.
barrons.com/articles/eli-lilly-ozempic-stock-upside-22292ed5
Paid articlePaid ARS Pharmaceuticals, Nuvalent, and More Stocks See Action From Activist Investors
barrons.com/articles/ars-pharmaceuticals-nuvalent-and-more-stocks-see-action-from-activist-investors-055469cc
Paid articlePaid Novo Nordisk parent refiles US application on Catalent deal: The parent of Wegovy producer Novo Nordisk has refiled an application to the U.S ...
reuters.com/markets/deals/novo-nordisk-parent-refiles-us-application-catalent-deal-2024-04-08/
With Elon Musk, Does the Good Outweigh the Bad?: Call it the duality of Musk: The actions of the billionaire entrepreneur both inspire and dismay.
wsj.com/business/autos/with-elon-musk-does-the-good-outweigh-the-bad-7087738f
Drugmaker seeks approval for China's first biosimilar Ozempic: A drugmaker in China has developed a biosimilar version of Novo Nordisk's popular diabetes drug ...
reuters.com/business/healthcare-pharmaceuticals/chinas-first-biosimilar-ozempic-drug-applies-approval-2024-04-03/
TriSalus Life Sciences, Inc. (TLSI) Q4 2023 Earnings Call Transcript: TriSalus Life Sciences, Inc. (NASDAQ:NASDAQ:TLSI) Q4 2023 Earnings Conference Call April 1 ...
seekingalpha.com/article/4681511-trisalus-life-sciences-inc-tlsi-q4-2023-earnings-call-transcript
Why A Pullback Is Bullish For IBD Stock Of The Day Novo Nordisk: Novo Nordisk is Friday's IBD Stock Of The Day. After hitting a record high in March ...
investors.com/research/ibd-stock-of-the-day/novo-nordisk-stock-pullback-weight-loss-drugs/
Hundreds of websites have been hawking fake Ozempic and other weight loss drugs. More may be coming
qz.com/fake-ozempic-websites-shut-down-1851411488
Why Eli Lilly And Rival Novo Nordisk Won't Be Troubled By Viking's Latest Weight Loss Data
seekingalpha.com/article/4681317-why-eli-lilly-and-rival-novo-nordisk-wont-be-troubled-by-vikings-latest-weight-loss-data
Paid articlePaid Amylyx Is Cutting 70% of Its Workforce and Pulling ALS Drug From the Market: The decision to remove Relyvrio from the market comes after the drug failed a Phase ...
barrons.com/articles/amylyx-job-cuts-relyvrio-als-drug-9db7a853
Paid articlePaid
Biocon leads India push into weight loss drugs as patents lapse: The Bengaluru-based firm is pivoting to anti-obesity therapies as patents for the blockbuster ...
dailymaverick.co.za/article/2024-04-08-biocon-leads-india-push-into-weight-loss-drugs-as-patents-lapse/
Eli Lilly vs. Novo Nordisk: Is this biotech stock ahead thanks to just one number?
boerse-online.de/nachrichten/aktien/eli-lilly-vs-novo-nordisk-hat-diese-biotech-aktie-dank-nur-einer-zahl-die-nase-vorn-20354696.html
Pfizer RSV Vaccine Could Get Wider Use. New Study Suggests a Benefit For All Adults.
barrons.com/articles/pfizer-fda-rsv-vaccine-shot-gsk-moderna-4b1d50cc
Paid articlePaid More than 65% upside: Is this unknown biotech stock now making Novo Nordisk and co. sweat?
boerse-online.de/nachrichten/aktien/mehr-als-65-upside-bringt-diese-unbekannte-biotech-aktie-novo-nordisk-und-co-jetzt-zum-schwitzen-20354064.html
The Ozempic boom: How the entire country of Denmark became a company town: Economists warn of “Nokia-style” overdependence on a single sector.
politico.eu/article/ozempic-boom-entire-country-kalundborg-denmark-became-company-town-pharma-novo-nordisk/
Abu Dhabi Consolidates Pharma Assets to Form Life Sciences Firm: Abu Dhabi sovereign wealth fund ADQ is consolidating some of its pharmaceutical assets to create ...
bloomberg.com/news/articles/2024-04-01/abu-dhabi-consolidates-pharma-assets-to-form-life-sciences-firm
Paid articlePaid
The race to develop the next generation of weight-loss drugs: Novo Nordisk and Eli Lilly, plus a clutch of rivals, aim to cut side effects while treating ...
ft.com/content/864631da-24d2-4d18-96b2-d2cb450edd5b
Paid articlePaid
Danone CEO downplays threat of weight loss drugs on food producers: 'We see ourselves as extremely complementary'
cnbc.com/2024/04/04/danone-ceo-downplays-threat-of-weight-loss-drugs-on-food-producers.html
Unlock your future with a Degree from Bar Ilan University
jpost.com/special-content/unlock-your-future-with-a-degree-from-bar-ilan-university-795932
Ozempic Babies: Doctors Want Safety Data on Obesity Shots During Pregnancy: A surprising thing is happening to some women on weight-loss drugs who’ve struggled ...
bloomberg.com/news/articles/2024-04-18/ozempic-babies-doctors-want-safety-data-on-obesity-shots-during-pregnancy
Even more doses of Eli Lilly's Zepbound and Mounjaro are officially in a shortage, FDA says
qz.com/eli-lilly-zepbound-shortage-fda-1851416991
Hanover: Federal Cartel Office approves Cardior takeover: The competition authority has no objections to the new owner Novo Nordisk. The Danes want to buy the ...
neuepresse.de/wirtschaft/regional/hannover-bundeskartellamt-genehmigt-cardior-uebernahme-XW42UM2WENCUFIMJY5IDDCXGEQ.html
Paid articlePaid
Ozempic's latest reported side effect: pregnancy: A number of women are reporting unplanned pregnancies while taking drugs like Ozempic.
axios.com/2024/04/18/ozempic-pregnancy-weight-loss-drugs-fertility-report
Costco enters a controversial industry with its latest move: Costco is expanding one of its beloved programs to include coverage of a growing trend that has ...
thestreet.com/retail/costco-enters-a-controversial-industry-with-its-latest-move
Sleep Apnea Reduced in People Who Took Zepbound, Eli Lilly Reports: The company reported results of clinical trials involving Zepbound, an obesity drug in the ...
nytimes.com/2024/04/17/health/sleep-apnea-obesity-zepbound.html
Copenhagen's Børsen Tower Can Rise Again With Novo Nordisk's Help: Denmark should take lessons from the fire at Notre Dame — and how French luxury ...
bloomberg.com/opinion/articles/2024-04-16/copenhagen-s-ravaged-stock-exchange-can-rise-again-with-novo-nordisk-help
Paid articlePaid
Stigmatization affects the psychology of people with obesity: Every year, Novo Nordisk highlights a special topic from the complex clinical picture of obesity in ...
medical-tribune.de/medizin-und-forschung/artikel/die-unsichtbare-last-des-stigmas
Cardior bosses: “The market for our new drug is huge”: 65 million people worldwide suffer from heart failure. The Hanover company Cardior has developed a new ...
neuepresse.de/wirtschaft/regional/cardior-chefs-der-markt-fuer-unser-neues-medikament-ist-riesig-EQCAWCCSWJDGTOTSVFQV3CIGVA.html
Paid articlePaid Zoetis Stock Falls on Concerns Over Pet Arthritis Drugs. Company Says They’re Safe.
barrons.com/articles/zoetis-stock-pet-arthritis-drugs-b3001b06
Paid articlePaid
Major investors say AstraZeneca boss is ‘massively underpaid’ on $21.5 million salary, despite earning more than double Novo Nordisk’s CEO
fortune.com/europe/2024/04/10/astrazeneca-boss-pascal-soriot-pay/
Paid articlePaid
Obesity-drug power duo Novo Nordisk and Eli Lilly have room to run, analysts say: BMO analysts cut price target for Amgen, another contender in the weight-loss ...
marketwatch.com/story/obesity-drug-power-couple-novo-nordisk-and-eli-lilly-still-have-room-to-run-analysts-say-c37743b9
Ozempic slimming injection: How pharmaceutical companies play patients off against each other
berliner-zeitung.de/open-source/abnehmspritze-ozempic-wie-pharmakonzerne-patienten-gegeneinander-ausspielen-li.2203936
Costco enters a controversial industry with its latest move: The retail giant is expanding one of its beloved programs to include a growing trend.
charlotteobserver.com/news/business/article287364065.html
Eli Lilly (LLY), Novo (NOVOB DC) Risk Missing High Expectations, Goldman Says: The weight loss drug frenzy that’s driven Eli Lilly & Co. and Novo Nordisk A/S ...
bloomberg.com/news/articles/2024-04-12/lilly-novo-euphoria-risks-disappointing-investors-goldman-says
Paid articlePaid AstraZeneca there: That's why these biotech stocks are now making hearts beat faster on Wall Street
boerse-online.de/nachrichten/aktien/astrazeneca-dabei-darum-lassen-diese-biotech-aktien-an-der-wall-street-jetzt-herzen-hoeher-schlagen--20354827.html
Johnson & Johnson just bought a second big heart device company: The healthcare giant has agreed to acquire Shockwave Medical in a $13.1 billion deal
qz.com/johnson-and-johnson-shockwave-medical-acquisition-1851390357
How the 'Oh-Oh-Oh Ozempic' Commercial Song Made a Musician $1 Million: David Paton's 1974 song "Magic" has been repurposed as the theme ...
entrepreneur.com/business-news/ozempic-song-used-in-commercial-makes-70s-rockers-millions/472492
3M Could Lose Its Elite Dividend Status After 64 Years. What It Means for the Stock.
barrons.com/articles/3m-lose-elite-dividend-status-23337728
Paid articlePaid
Novo Nordisk: Deal with Ginkgo Bioworks is expanded - the details: The Danes are further expanding their partnership with the synthetic biology specialist.
deraktionaer.de/artikel/pharma-biotech/novo-nordisk-deal-mit-ginkgo-bioworks-wird-erweitert-die-details-20354834.html
Wegovy’s heart benefits are not just linked with weight loss, new study suggests: Heart-failure patients with diabetes may shed fewer pounds on Wegovy but still ...
marketwatch.com/story/wegovys-heart-benefits-are-not-just-linked-with-weight-loss-new-study-suggests-1bfcf903
Meet Europe’s Mag 18. Novo Nordisk Stock, ASML, and Others Can Rival the Mag Seven.
barrons.com/articles/novo-nordisk-asml-lvmh-nestle-european-mag-stocks-554d95c7
Paid articlePaid Novo Nordisk: The Moat Won't Last Forever: Novo Nordisk is currently the preeminent player in this burgeoning GLP-1 market space. Click here to read an analysis ...
seekingalpha.com/article/4682909-novo-nordisk-the-moat-wont-last-forever
Paid articlePaid These Stocks Are Moving the Most Today: Trump Media, Tesla, Maxeon, Tilray, and More
barrons.com/articles/stock-market-movers-c65f7589
Paid articlePaid
Eli Lilly's weight loss injection: explosive device for the German health system: Eli Lilly, the largest pharmaceutical company in the world, will soon be ...
capital.de/wirtschaft-politik/eli-lillys-abnehmspritze--sprengsatz-fuers-deutsche-gesundheitssystem-34607690.html
I Invested in Ozempic—It Taught Me a Valuable Lesson: It is now more valuable than Tesla.
newsweek.com/i-invested-ozempic-it-taught-me-valuable-lesson-1887867
Eli Lilly's weight loss drug Zepbound is officially in a shortage: The FDA says some doses of the drug will be in limited supply until the end of April
qz.com/weight-loss-drug-zepbound-fda-shortage-eli-lilly-1851384557
Paid articlePaid Bio-Techne: Secular Growth Opportunities Always Exhibit Financial Excellence: Bio-Techne’s focus on stable and lucrative life science research market led to ...
seekingalpha.com/article/4682129-bio-techne-secular-growth-opportunities-always-exhibit-financial-excellence-tech-stock
Paid articlePaid
Citi Monitors Competitive Threats To Eli Lilly, Says It Is Positioned To Maintain Leadership And Expand -
benzinga.com/analyst-ratings/analyst-color/24/04/38055169/citi-monitors-competitive-threats-to-eli-lilly-says-it-is-positioned-to-maintain-le
Ozempic and Wegovy: How dangerous is the weight loss injection?: The weight loss injection is considered a new miracle cure. Losing pounds has never been easier ...
augsburger-allgemeine.de/kultur/gesellschaft/ozempic-und-wegovy-wie-gefaehrlich-ist-die-abnehmspritze-id69853691.html
Paid articlePaid Ozempic's cheaper side, weight loss drug competition, and Amazon delivery: Pharma news roundup
qz.com/ozempic-weight-loss-drug-amazon-delivery-novo-nordisk-1851373018
Paid articlePaid Omega Therapeutics And Novo Nordisk Collaboration: A Cautious 'Buy': Omega Therapeutics has signed a collaboration with Novo Nordisk to develop a drug for ...
seekingalpha.com/article/4681343-omega-therapeutics-novo-nordisk-collaboration-cautious-buy
Paid articlePaid Ozempic: Manufacturer of the weight loss injection comes under pressure due to overpricing
berliner-zeitung.de/gesundheit-oekologie/ozempic-hersteller-der-abnehmspritze-geraet-wegen-ueberteuertem-preis-unter-druck-li.2201409
“Strong Buy”: 150% chance jumps in: Discover the next high-flyer stock in the obesity space.
deraktionaer.de/artikel/pharma-biotech/strong-buy-150-chance-springt-an-20354094.html
The most valuable company in Europe grabs the most valuable startup in Germany - Business Punk
business-punk.com/2024/03/das-wertvollste-unternehmen-europas-krallt-sich-das-wertvollste-startup-deutschlands/
Ozempic Could Sell at a Profit for $57 a Year, Report Says. It’s Priced at $11,600.
barrons.com/articles/ozempic-wegovy-novo-nordisk-c5659256
Paid articlePaid Trump’s Wealth Is Surging as Investors Snap Up His Company’s New Shares: The launch of Trump Media under the DJT ticker is adding billions to Former President ...
barrons.com/articles/how-rich-is-trump-net-worth-djt-d65a19f9
Paid articlePaidQuick Glance: Trump's Truth Social Stock Surges Despite Company Losses
- Shares of Donald Trump's social media platform Truth Social have seen a significant increase in their first days of trading.
- Despite the company's lack of profit and meager quarterly revenue, it has been valued at over $8 billion.
- Experts suggest that the stock surge is driven more by Trump's political supporters than financial fundamentals.
- While the future of Truth Social remains uncertain in the competitive social media industry, it may serve as a platform for Trump's future media ventures.
A month's supply of the weight loss drug Ozempic costs less than $5 to make, study says
qz.com/ozempic-5-cost-study-1851370294
Paid articlePaid Irish Economy Forecast to Return to Growth, Easing Drag on Eurozone: The eurozone economy may be freed of a headwind that enfeebled growth in 2023 ...
wsj.com/economy/irish-economy-forecast-to-return-to-growth-easing-drag-on-eurozone-6355de20
Merck Scores Major Drug Approval, Easing Pain From Keytruda Patent Expiration: Merck’s newly approved drug treats a rare heart condition called pulmonary ...
barrons.com/articles/merck-drug-approval-keytruda-patents-11d73480
Paid articlePaid This Vaccine Maker Sits on Cash Almost Equal to Its Market Value: BioNTech partnered with Pfizer in the leading Covid vaccine, but sales have slid in recent ...
barrons.com/articles/biontech-cash-market-value-6ce8027e
Paid articlePaid Novo ready to seek German insurance coverage of Wegovy for heart use: Novo Nordisk said it plans to seek coverage by Germany's public health insurance scheme for ...
reuters.com/business/healthcare-pharmaceuticals/novo-ready-seek-german-insurance-coverage-wegovy-heart-use-2024-03-25/
Moderna Stock Pops as New Covid-19 Vaccine Shows Positive Results: Moderna’s ‘next generation,’ Covid-19 vaccine has shown a higher immune response to the virus ...
barrons.com/articles/moderna-stock-pops-price-vaccine-55ef1af0
Paid articlePaid Popular Appetite Suppressant Ozempic Can Be Made For Less Than $5 a Month, New Research Suggests
entrepreneur.com/business-news/ozempic-could-be-profitably-manufactured-much-cheaper-study/471823
Next
New to NewsWall?
Sign up now to get your own personalized news!
Trending topics